Skip to main content

Table 2 Effect of Matrine salvianolic acid B salt on AST and ALT in rats

From: Hepatoprotective effect of Matrine salvianolic acid B salt on Carbon Tetrachloride-Induced Hepatic Fibrosis

Treatment Doses (mg/kg) AST (U/L) ALT (U/L)
Normal control —— 45.59 ± 3.68 32.12 ± 14.09
CCl4 —— 211.20 ± 42.07## 221.24 ± 42.35##
Matrine+ CCl4 50 142.87 ± 36.99** 138.87 ± 32.67**
Salvianolic acid B+ CCl4 150 104.22 ± 20.67** 154.92 ± 60.64**
Matrine salvianolic acid B Salt+ CCl4 25 159.10 ± 46.19** 169.92 ± 51.42**
50 119.80 ± 25.69** 144.33 ± 44.93**
100 102.49 ± 25.71**b 96.09 ± 27.28**ac
Fu fang bie jia ruan gan pian+ CCl4 780 110.3 ± 26.62** 117.26 ± 40.70**
  1. Data is expressed as the mean±SD (n = 12).
  2. ##p < 0.01 vs. the normal control group; **p < 0.01 vs. the CCl4-treated group;
  3. ap < 0.05, bp < 0.01 vs. the Matrine group; cp < 0.01 vs. the Salvianolic acid B group.